Pharmaceutical sales representatives and physicians: Ethical considerations of a relationship

Journal of Medicine and Philosophy

Volumn 21, Issue 1, 1996, Pages 83-99

  Peppin, John F ^a  

^a University of Wisconsin   (United States)

Author keywords

Conflict of interest; Influence; Pharmaceutical sales representatives

Indexed keywords

ADVERTIZING; ANALYTICAL APPROACH; ARTICLE; CONFLICT OF INTEREST; DOCTOR PATIENT RELATION; DRUG INDUSTRY; ETHICS; GIFT GIVING; HEALTH CARE AND PUBLIC HEALTH; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; MEDICAL ETHICS; PUBLIC RELATIONS; TRUST;

ANALYTICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ADVERTISING; CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICAL ANALYSIS; ETHICS, MEDICAL; GIFT GIVING; HUMANS; INFORMATION DISSEMINATION; INTERPROFESSIONAL RELATIONS; MANAGED CARE PROGRAMS; PHYSICIAN-PATIENT RELATIONS; TRUST;

EID: 0030079367     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1093/jmp/21.1.83     Document Type: Article

References (51)

1. American College of Physicians (ACP) Ethics Committee: 1993, "Ethics case study: should drug makers support continuing medical education," ACP Observer, 13, pp. 12-13.
2. American Law Institute: 1957, Restatement (Second) of the Law-Agency § 13.
3. American Medical Association Poll: 1992 and 1993, "Public opinion on health care issues."
4. American College of Legal Medicine: 1991, Legal Medicine, 2nd ed., Mosby Year Book, St. Louis.
5. Andrews, K.R.: September/October 1989, 'Ethics in practice,' Harvard Business Review, pp. 99-104.
6. Armey, Representative R.: November 4, 1994, CNN Crossfire Interview, Texas.
7. Arrow, K.J.: 1972, 'Gifts and exchanges,' Philosophy and Public Affairs, 1, pp. 355-360.
8. Bauer, R.A., and Field, M.G.: 1962, 'Ironic contrast: US and USSR drug industries,' Harvard Business Review, 40, pp. 89-97.
9. Berman, J.L.: 1990, 'Physicians and the pharmaceutical industry,' Annals of Internal Medicine, 113, p. 900.
10. Cialdini, R.B.: 1984, Influence: The New Psychology of Modern Persuasion, Quill Publishers, New York.
11. Chren, M. et al.: 1989, 'Doctors, drug companies, and gifts,' Journal of the American Medical Association, 262, pp. 3448-3451.
12. Cohen, E.P.: 1988, 'Direct-to-the-public advertisement of prescription drugs,' New England Journal of Medicine, 318, pp. 373-376.
13. Dacso, C.C. and Rodning, C.B.: 1985, 'A physician/medical industrial ethos,' The American Journal of Medicine, 79, p. 675.
14. Engelhardt, H.T.: 1995, The Foundations of Bioethics, 2nd ed., Oxford University Press, New York.
15. Finnis, J.: 1983, Fundamentals of Ethics, Georgetown University Press, Washington D.C.
16. Freeman, L.H. and Keetz, B.: 1987, 'The physician and the pharmaceutical detail: an ethical analysis,' The Journal of Medical Humanities and Bioethics, 8, pp. 34-39.
17. Gallup Poll: 1993, 'Confidence in institutions.'
18. Gouldner, A.W.: 1960, 'The norm of reciprocity: a preliminary statement,' American Sociological Review, 25, pp. 161-178.
19. Greenberg, D.S.: 1990, 'Washington perspective [comment],' The Lancet, 336, pp. 1568-1569.
20. Guralnik, D.B. (ed.): 1979, Webster's New World Dictionary, 2nd Edition, William Collins Publishers, Inc., New York.
21. Kippen, A.: 1990, 'Doctored results,' The Washington Monthly, October, pp. 38-42.
22. Kohrmann, A.F.: 1991, 'Pediatricians' relation to for-profti corporations,' Pediatrics, 88, pp. 1280-1281.
23. Lexchin, J.: 1987, 'Pharmaceutical promotion in Canada: convince them or confuse them,' International Journal for Health Services, 17, pp. 77-89.
24. Lexchin, J.: 1988, 'The medical profession and the pharmaceutical industry: an unhealthy alliance,' International Journal of Health Services, 18, pp. 603-616.
25. Lober, C.W.: 1993, 'Ethics in pharmaceutical advertising,' Dermatology Clinics, 11, pp. 285-288.
26. Macgregor, A.J.: 1992, 'Physicians and pharmaceutical companies,' Canadian Medical Association Journal, 146, p. 327.
27. Mackowiak, J.I, and Gagnon, J.P: 1985, 'Effects of promotion on pharmaceutical demand,' Social Science and Medicine 20, pp. 1191-1197.
28. Maralik, S.: 1992, 'Advertising, pharmaceutical industry, and dermatology [letter],' International Journal of Dermatology, 31, p. 144.
29. Margolis, L.H.: 1991, 'The ethics of accepting gifts from pharmaceutical companies,' Pediatrics, 88, pp. 1233 & 1237.
30. Margolis, L.H.: 1992, 'In reply [letter],' Pediatrics, 90, p. 281.
31. Miller, R.R.: 1974, 'Prescribing habits of physicians,' Drug Intelligence and Clinical Pharmacy, 8, February, pp. 81-91.
32. Modell, W.: 1961, 'The drug explosion,' Clinical Pharmacology and Therapeutics, 2, p. 3.
33. National Opinion Research Center (NORC): 1991, Occupational prestige ratings.'
34. Peppin, J.: 1995, 'Physician neutrality and patient autonomy in advanced direc-tive decisions,' Issues in Law and Medicine, 11, pp. 13-27.
35. Peppin, J: 1995, 'An Engelhardtian perspective on pharmaceutical sales representative interactions with phyicians/ (unpublished).
36. ProAmerica Managed Care, Inc.: 1993, [letter], Fort Worth Texas.
37. Randall, T.: 1991, 'Kennedy hearings say no more free lunch-or much else- from drug firms,' Journal of the American Medical Association, 265, pp. 440-441.
38. Rawlins, M.D.: 1984, 'Doctors and the drug makers,' The Lancet, 328, pp. 276-278.
39. Relman, A.S.: 1987, 'Practicing medicine in the new business climate,' New England Journal of Medicine, 316, pp. 1150-1151.
40. Richards, J.W.: 1993, 'AAFP white paper on proprietary relationships: just do the right thing,' American Family Physician, 44, pp. 2023-2024, 2026, 2028.
41. Rodwin, M.A.: 1993, Medicine, Money, and Morals, Oxford University Press, New York.
42. Rudinow, J.: 1978, 'Manipulation,' Ethics, 88: pp. 338-347.
43. Schiedermayer, D.: 1993, 'The free lunch syndrome: physicians and the pharmaceutical industry,' Christian Medical Dental Society Journal, Summer, pp. 30-33.
44. Shaughnessy, A.: 1988, 'Drug promotion in a family medicine training center,' The Journal of The American Medical Association, 260, p. 926.
45. Shimm, D.S. and Spece, R.G.: 1991, 'Industry reimbursement for entering patients into clinical trials: legal and ethical issues,' Annals of Internal Medicine, 115: pp. 148-151.
46. Silverman, M. and Lee, P.R.: 1974, Pills, Profits, and Politics, University of California Press, Berkeley.
47. Smith, M.C.: 1975, Principles of Pharmaceutical Marketing, Lea & Febiger, Philadelphia.
48. Soumerai, S.B. and Avorn, J.: 1984, 'Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions,' Millbank Memorial Fund Quarterly, 62, pp. 447-474.
49. Terry, P.B.: 1991, 'Pulmonary physicians, principles, and pharmaceuticals,' Chest, 100, pp. 223-226.
50. Walton, D.: 1992, The Place of Emotion in Argument, The Pennsylvania State University Press, University Park.
51. Waud, D.R.: 1992, 'Pharmaceutical promotions - A free lunch?' New England Journal of Medicine, 327, pp. 351-353.